Key facts
- Robbins Geller Rudman & Dowd LLP is investigating GeneDx Holdings Corp.
- The investigation concerns potential securities law violations.
- The relevant period for stock purchases is April 16, 2025, to May 4, 2026.
- Investors have until August 3, 2026, to seek appointment as lead plaintiff.
Robbins Geller Rudman & Dowd LLP has announced an investigation into GeneDx Holdings Corp. (NASDAQ: WGS) concerning alleged securities law violations. The investigation covers purchasers of GeneDx Holdings Corp. common stock who bought shares between April 16, 2025, and May 4, 2026. Investors who incurred substantial losses during this period have the opportunity to lead the class action lawsuit. The deadline for these investors to seek appointment as lead plaintiff is August 3, 2026.